Ortho Development earns FDA clearance for Trivecta hip system


Ortho Development earned FDA 510(k) clearance for its Trivecta hip system, the devicemaker said March 14.

Trivecta has a triple-taper femoral stem to fit a diverse range of patient anatomies, according to a news release. It also has sintered beads for initial and long-term stability, and Hydroxyapatite encourages biological fixation.

The implant will be available in the U.S. starting in the second quarter of 2024.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers